- Home
- NL vs OBIO Comparison
NL vs OBIO Comparison
Compare NL & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NL | OBIO |
|---|---|---|
| Founded | 1891 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 246.2M |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NL | OBIO |
|---|---|---|
| Price | $5.63 | $4.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | 54.1K | ★ 204.9K |
| Earning Date | 03-09-2026 | 03-12-2026 |
| Dividend Yield | ★ 10.72% | N/A |
| EPS Growth | N/A | ★ 33.13 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $158,285,000.00 | $33,482,000.00 |
| Revenue This Year | $9.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 8.46 | ★ 1169.22 |
| 52 Week Low | $5.04 | $2.20 |
| 52 Week High | $9.27 | $5.42 |
Technical Indicators
Market Signals| Indicator | NL | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 38.88 | 52.51 |
| Support Level | $5.28 | $4.08 |
| Resistance Level | $5.82 | $4.88 |
| Average True Range (ATR) | 0.30 | 0.31 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 7.79 | 50.38 |
Price Performance
Historical ComparisonAbout NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.